About FDA
-
-
Academia MOUs
MOU No. | Purpose | Parties | FDALead | Effective | Expiration |
| 224-11-0024 | Establishes a collaborative framework between the FDA and the University of Florida through a variety of programs, including collaborative education and research. | University of Florida | CDER Ryan Chatman (301) 796-2106 | 09-21-2011 | 09-20-2016 |
| Establishes terms of collaboration between FDA and UMD to support shared interest in scientific progress through a variety of programs such as sabbaticals, postdoctoral fellowships, and student internships. | University of MD | OC Eileen Parish (301) 796-8522 | 09-04-2002 | Indefinite | |
| Establishes terms of collaboration between FDA and VA Polytechnic Institute to support shared interest in scientific progress through a variety of programs such as sabbaticals, postdoctoral fellowships, and student internships. | University of Houston | CDRH Michelle Chenault (240) 276-3815 | 03-29-2003 | Indefinite | |
| Establishes terms of collaboration between FDA and VA Polytechnic Institute to support shared interest in scientific progress through a variety of programs such as sabbaticals, postdoctoral fellowships, and student internships. | VA Polytechnic Institute | OC Mary Poos (301) 827-2825 | 03-13-2003 | Indefinite | |
| Establishes terms of collaboration between FDA and Howard University to support shared interest in scientific progress affecting human and animal health and medicine through a variety of programs such as sabbaticals, postdoctoral fellowships, and student internships. | Howard University | OC Eileen Parish (301) 796-8522 | 05-29-2003 | Indefinite | |
| Establishes a framework for collaborative research and development and emergency triage response efforts on the subject of Homeland Security. | University of CA, Lawrence Livermore National Laboratory | ORA Jeanne Roman (301) 827-0947 | 04-14-2004 | Indefinite | |
| To establish terms of collaboration between FDA and BWH to support shared interests and to begin the initiative "The FDA Brigham Elective Program for Residents in the Department of Medicine." | Brigham and Women's Hospital | CDRH Nancy Pluhowski (301) 827-2890 | 05-09-2006 |
| |
| Establishes collaboration between FDA, Duke University, and Duke University Health System, Inc. in sharing scientific information. | Duke University Duke University Health System, Inc. | CDRH Nancy Pluhowski (301) 827-2890 | 09-18-2006 | Indefinite | |
| FDA and Duke agree to collaborate through steering committees and technical working groups, to develop strategic plans, set priorities, and leverage resources and expertise from multiple sources, including the private sector, toward the goals of identifying indicators of cardiovascular risk, predicting adverse cardiovascular events associated with therapeutic interventions, improving the clinical utility of biomarker technologies as diagnostic and assessment tools that facilitate the development of safer and more effective cardiovascular therapies, diagnostic, and assessment tools. | Duke University | OC Mary Poos (301) 827-2825 | 08-15-2006 | 08-15-2009 | |
| Establishes terms of collaboration between FDA/CBER and Yokohama City University in CBER's Collaborative Scientific Training Program (CSTP) which targets development of scientific tools for biological product evaluation and regulation. | Yokohama City University | CBER Dano Murphy (301) 827-0801 | 12-21-06 | 12-31-09 | |
| 225-07-6001 | Establishes the terms for collaborative research between the FDA and Stanford University to promote scientific progress in animal and human medicine. | Stanford University | CDRH Nancy Pluhowski (301) 827-2890 | 01-12-2012 | 11-11-2017 |
| Establishes terms of collaboration between FDA and the University of California, Davis Campus, to support shared interests that can be pursued through a variety of programs. | The University of California, Davis Campus | OC Mary Poos (301) 827-2825 | 12-07-07 | 12-07-12 | |
| To establish terms of collaboration between FDA and Duke, as a part of FDA's Critical Path Initiative. This MOU will serve as the basis of a Public Private Partnership hosted by Duke to systematically modernize the clinical trial process. | Duke University | OC Melissa Robb (301) 827-1516 | 09-22-2007 | Indefinite | |
| FDA and the Alliance for NanoHealth (ANH) agree to collaborate with multiple orginizations facilitated and coordinated through the ANH, to improve the safety and efficacy of nanoengineered products and speed their delivery to the patients who need them and the consumers who use them. | Baylor College of Medicine The University of Texas M.D. Anderson Cancer Center Rice University University of Houston The University of Texas Health Science Center at Houston Texas A&M Health Science Center The University of Texas Medical Branch at Galveston The Methodist Hospital Research Institute | OC | 02-12-2009 | 02-12-2011 | |
225-07-8008 replaces 225-02-8000 | To establish collaboration in the areas of advanced scientific training, information exchange and stimulation of cooperative research activities in biotechnology, bioethics, and nanotechnology, particularly with the Institute of NanoBioTechnology. | John Hopkins University | OC Eileen Parish (301) 796-8522 | 10-11-2007 | Indefinite |
225-07-8405 | Establishes terms of collaboration between FDA and the University System of MD to support their shared interest in scientific progress in the diverse disciplines that directly and indirectly affect human and animal health medicine. | University System of MD | OC Eileen Parish (301) 796-8522 | 07-12-2007 | 07-11-2017 |
| 225-09-0017 | Establishes terms of collaboration between FDA and Catholic University (CUA) to supporta variety of programs including research, public outreach, extension activities, cooperative international initiatives, disciplinary training, and exchange of scientists and staff, including sabbaticals, postdoctoral fellowships, and student internships. | Catholic University of America (CUA) | OC Eileen Parish (301) 796-8522 | 08-31-2009 | 08-30-2014 |
| 225-11-0022 | Establishes the terms for collaboration to promote shared interests, which can be pursued through a variety of programs including collaborative education research. | The Hamner Institutes for Health Sciences' including The Hamner-UNC Institute for Drug Safety Sciences | CDER Ryan Chatman (301) 796-2106 | 12-06-2011 | 12-06-2016 |
| 225-11-0011 | To promote scientific progress through exchange of scientific capital in Applied Physics Research in understanding continuous processing and control in micro reactors. | University of Washington | CDER David Morley (301) 796-1719 | 04-04-2011 | 04-04-2016 |
| 225-11-0003 | To set forth a framework for an alliance between FDA and GUMC. The MOU is intended to leverage the Parties' combined strengths, resources, and proximity for stimulating innovation in regulatory science, ethics, education, and training within the scope of FDA mission and the broad academic charge of GUMC. | Georgetown University Medical Center | OC Leslie D. Wheelock (301) 796-8450 | 02-24-2011 | 02-24-2016 |
| 225-11-0006 | Establishes the terms for collaboration to promote shared interests, which can be pursued through a variety of programs including collaborative education research | Regents of the University of California, San Francisco | CDER Ryan Chatman (301) 796-2106 | 02-18-2011 | 02-18-2016 |
| 225-11-0010 | To establish a framework for an alliance between FDA-OIP and the O'Neill Institute. | Georgetown University Law Center | OIP Katherine Bond (301) 796-8318 | 10-19-2011 | 10-19-2016 |
| 225-11-0012 | Forms the basis for the initial relations between FDA and the University of Hawaii for sabbaticals, research and scientific education. | University of Hawaii at Manoa, Office of Public Health Studies | OMH Michelle Yeboah (301) 796-4649 | 04-24-12 | Indefinite |
| 225-11-0015 | The Food and Drug Administration (FDA) and the Harvard Medical School, Department of Population Medicine (Harvard), collaborate in promoting scientific progress through exchange of scientific capital in promoting postmarket safety surveillance research. | Harvard Medical School | Gerald J. Dal Pan, MD, MHS (301) 796-2380 | 09-30-2011 | 09-29-2016 |
| 225-11-0020 | Establishes the terms for collaboration to promote shared interests, which can be pursued through various programs including collaborative education and research | The Trustees of Columbia University in the City of New York | CDER Mark Lauda (301) 796-0381 | 10-19-2011 | 10-19-2016 |
| 225-11-0025 | Establishes the terms for collaboration to promote shared interests, which can be pursued through various programs including collaborative education and research. | American College of Gastroenterology | CDER Donna J. Griebel (301) 796-4153 | 03-01-2012 | 03-01-2017 |
| 225-11-0030 | Establishes the terms for The United States Food and Drug Administration (FDA) and Duke University (the Parties)to share interests in promoting scientific progress through exchange of scientific capital in an effort to enhance the assessment of safety and efficacy of FDA-regulated products. | Duke University | CDER | 11-08-2011 | 11-08-2016 |
| 225-12-0002 | Establishes the terms for collaboration to promote these shared interests, which can be pursued through a variety of programs including collobrative research, public outreach, extension activities, cooperative international initiatives, and disciplinary training. | Austen BioInnovation Institute in Akron | CDRH Michelle McMurry-Heath (301) 796-7647 | 12-15-2011 | 12-15-2016 |
| 225-12-0004 | Establishes the collaboration between The United States Food and Drug Administration (FDA) and Thomas Jefferson University to share interests in promoting scientific progress through exchange of scientific capital in Clinical Pharmacology Training and Research Program. | The Thomas Jefferson University | CDER Ryan Chatman (301) 796-2106 | 12-09-2011 | 12-09-2016 |
| 225-12-0010 | Forms the basis betweenThe Food and Drug Administration (FDA) and the Massachusetts Institute of Technology (MIT)to collaborate in promoting scientific progress through exchange of scientific capital in training and research and foresee benefits from the mutual exchange of training and research expertise. | Massachusetts Institute of Technology (MIT) | CDER Nancy Pluhlowski (301) 796-6660 | 12-09-2011 | 04-15-2017 |
| 225-12-0011 | Forms the basis for the initial relations between FDA and the University of Hawaii, College of Pharmacy for sabbaticals, research and scientific education | University of Hawaii Hilo, College of Pharmacy | OMH Michelle Yeboah (301) 796-4649 | 03-30-2012 | Indefinite |
| 225-12-0018 | Establishes the terms between the Food and Drug Administration (FDA) and Stanford University (Stanford) to promote scientific progress through exchange of scientific capital in diverse fields of science that affect human and animal health and medicine. | Stanford University | Gerald J. Dal Pan, MD MHS(301) 796-2380 | 05-17-2012 | Indefinite |
| 225-12-0026 | Forms the basis for the initial relations between the FDA and The University of Nebraska (UNMC) for sabbaticals, research and scientific education. | University of Nebraska | OMH Michelle Yeboah (301) 796-4649 | 06-28-2012 | 06-28-2017 |
| 225-12-0029 | Forms the basis for the initial relations between FDA and Meharry Medical College (Meharry) for sabbaticals, research and scientific education. | Meharry Medical College | OMH Michelle Yeboah (301) 796-4649 | 06-21-2012 | Indefinite |
| 225-12-0036 | Establishes terms of collaboration between The United States Food and Drug Administration (FDA) and the University of Medicine and Dentistry of New Jersey (UMDNJ) to share interests in promoting scientific progress through exchange of scientific capital in the clinical pharmacology training and research program. | University of Medicine and Dentistry of New Jersey | CDER | 06-19-2012 | 06-19-2017 |
| IL Inst. Tech., participation in short courses, workshops, & training programs in food safety and technology. | IL Inst. Tech | CFSAN Don Zink (240) 402-1693 | 09-03-1993 | Indefinite | |
| Establishes terms of collaboration between FDA and UMBC to support collaboration on specific projects related to biotechnology process validation, but can serve as a basis for future collaboration in other areas. | University of MD Baltimore County | CDER Dr. Kurt Brorson (301) 796-2193 | 07-25-2003 | Indefinite |
-
-
